Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and ...

You likely use them every single day - but some of your home appliances could be emitting harmful pollutants, according to a ...

A new study has measured the levels of indoor air pollution emitted by everyday home appliances, revealing which ones you ...

Avacta reported new pharmacology data on its second oncology asset, FAP-Exd (AVA6103), on Thursday, showing sustained tumor ...

Detailed price information for Beone Medicines Ltd (ONC-Q) from The Globe and Mail including charting and trades.

Investing.com -- Avacta Group on Thursday announced new pharmacology data for its cancer drug FAP-Exd (AVA6103), showing sustained tumor-specific release of its active ingredient over five days.

Eilean Therapeutics announced the advancement of ZE74-0282 into first-in-human clinical development. ZE74-0282 is a novel, highly selective inhibitor of the mutated Janus kinase 2 (JAK2) V617F variant ...

Phase III is intended to generate meaningful biological data on potential drug compounds prioritized by YuvaBio’s classifier, ...

A combination of the antibody-drug conjugate enfortumab vedotin (Padcev) and the PD-1 inhibitor pembrolizumab (Keytruda) ...

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

A recent study has found that two cannabis derivatives may aid in ovarian cancer treatment. The research indicates that CBD ...

BIO-Europe Startup Spotlight returns to Lisbon in March 2026, showcasing Europe’s top early-stage biotech pitches to industry ...